Clinical Trials Logo

Chronic Consumption of Cannabis clinical trials

View clinical trials related to Chronic Consumption of Cannabis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04836611 Recruiting - Clinical trials for Chronic Consumption of Cannabis

Cannabinoides Concentrations and Hyperemesis Syndrom Occurrence in Regular Cannabis Consumer (CANEMESE)

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The Cannabinoide Hyperemesis Syndrom (CHS) is defined as a recurrent syndrome of intractable vomiting that occurs in chronic cannabis consumers. The diagnosis is linked to clinical criteria only. The physiopathology of CHS is unknown and we observe an increase of cases with this syndrom since 2016 (Schreck et al., 2018). The aim of this study is to investigate the involvement of exogenous cannabinoids concentrations in chronic cannabis users in the occurrence of CHS.